Equitalist

Apollo Hospitals Enterprise Limited

BSE: 508869 | NSE: APOLLOHOSP

Sector: Healthcare | Industry: Hospital

Apollo hospital logo
REVENUE
₹ 25,229 Crore
Topline YoY ▲ 15.8%
GROSS PROFIT
₹ 12,153 Crore
Cost efficiency ▲ 15.9%
EBITDA
₹ 3,769 Crore
Operating leverage ▲ 24.7%
NET PROFIT
₹ 2,003 Crore
Net profitability ▲ 33.1%

ABOUT COMPANY

Apollo Hospitals Enterprise Ltd. ( hereinafter as “Apollo“ or “The Company” or “Company”) was incorporated in 1979 and founded by Dr. Prathap C Reddy. The company is the India’s first corporate hospital.

The company operates under three segments such as:

  • Apollo Hospitals Enterprise Limited (AHEL) is in hospital segment which provides tertiary and quaternary care, offers cardiology, oncology, neurology, gastroenterology, transplants and robotic surgery.
  • Apollo HealthCo Limited (AHL) is in pharmacy segment which offers omnichannel pharmacy distribution and digital health solutions through Apollo 24/7.
  • Apollo Health and Lifestyle Limited (AHLL) is in diagnostic segment which offers everyday healthcare such as stay facilities, boutique birthing centres, multi-speciality clinics, diagnostic centres, dental and dialysis facilities, fertility services and preventive care.
Metric Value
Beds 10,970
Hospitals 78
Pharmacies 7,289
Diagnostic Centres 2,500+
Clinics 300+
Registered Users of Apollo 24|7 47 million+
Category Hospitals Capacity Census Beds Operational Census Beds
Overall Total 78 10,970 9,620
Owned Hospitals 49 9,481 8,131
Managed Hospitals 6 790 790
Day Surgery & Cradle (AHLL) 23 699 699
Note: Capacity beds include only census capacity beds and doesn’t include emergency
Internal Medicine Dermatology Colorectal Surgery Cardiac Sciences Obstetrics & Gynaecology
Endocrinology Oncology Ophthalmology Neurosciences Pediatrics Hospital
Nephrology Vascular Surgery Urology Interventional Radiology
Gastroenterology Bariatric Surgery Orthopedics Cosmetology
Pulmonology General Surgery Emergency Medicine Dentistry
Location Number of hospital Day Surgery and Cradle & Birthing centres Diagnostics centers Clinics Dialysis centers Dental centers Pharmacy outlets Total
Domestic 49 22 2,212 401 146 219 6,626 9,675
International 2 N/A N/A N/A N/A N/A N/A 2
Note: The international sites consist of Apollo information centers and are not part of healthcare services.
Location Type Total Count Breakdown / Regions Note
National 32 total (28 States, 4 Union Territories) 28 States, 4 Union Territories
International 5 Regions / Countries Africa, Middle East, Bangladesh, Bahrain, Myanmar The international sites consist of Apollo information centers and are not part of the healthcare services.
State City Number of Hospitals State City Number of Hospitals State City Number of Hospitals
Assam Assam 2 Maharashtra Mumbai 3 Telangana Kakinada 1
Chhattisgarh Bilaspur 1 Nashik 1 Karimnagar 1
Delhi Delhi 6 Pune 4 Uttar Pradesh Kanpur 1
Karnataka Bangalore 9 Odisha Bhubaneshwar 1 Lucknow 1
Karnataka 1 Tamil Nadu Chennai 12 Noida 1
Mysore 1 Karaikudi 1 West Bengal Kolkata 3
Kerala Cochin 1 Madurai 2 Overseas (Managed) Bahrain 1
Madhya Pradesh Bhopal 1 Trichy 1 Overseas (Managed) Bangladesh 1
Maharashtra Lavasa 1 Telangana Hyderabad 8
State / Union Territory Number of Pharmacy State / Union Territory Number of Pharmacy State / Union Territory Number of Pharmacy
Andaman 7 Himachal Pradesh 8 Telangana 998
Andhra Pradesh 1030 Jharkhand 45 Tripura 7
Assam 46 Karnataka 1064 Uttarakhand 42
Bihar 30 Kerala 146 West Bengal 918
Chandigarh 4 Madhya Pradesh 60 Punjab 78
Chhattisgarh 98 Maharashtra 268 Rajasthan 122
Goa 61 New Delhi 138 Tamil Nadu 1309
Gujarat 230 Orissa 202
Haryana 109 Puducherry 25
AHEL
Category Value Details
Owned, Subsidiaries & Associates 49 Hospitals
Managed 6 Hospitals
Cradle and Spectra 23 Hospitals (excludes Brand Operations and Management Agreement)
Total 78
AHLL
Facility / Service Type Count
Primary Clinics 318
Sugar Clinics 78
Dental Clinics 280
Birthing Facilities* 34
Spectra Facilities# 23
Diagnostic Centres 2,500+
Dialysis Centres 167
* Includes Brand Operations and Management Agreement (BOMA)
AHL
Metric Value
Stores 7,289
Cities and Towns 1,300+
Transactions p.a. ~360 million+

Earning Calls Summary

Management Earnings Calls

Quarterly concall summaries, management commentary tracker & key metrics

Q2     FY 2027

Q2 Revenue Up 23%; 24/7 Turns Cash Positive; PAT Surges 32%

Management opened noting another quarter of strong performance across all three verticals — healthcare services, HealthCo, and AHLL — with sustained double-digit growth building on prior-quarter momentum. The broader healthcare sector is witnessing strong momentum with increased participation and investments flowing in, reflecting confidence in India's healthcare opportunity.

Q2 FY27 REVENUE GROWTH 23% YoY to ₹7,615 crores
Q2 FY27 CONSOLIDATED PAT GROWTH 32% YoY to ₹630 crores
APOLLO HEALTHCO EBITDA GROWTH 75% YoY to ₹193 crores (24/7 cash positive at ₹1 crore)
Key Takeaway: Q2 FY27 consolidated revenue grew 23% YoY to ₹7,615 crores with EBITDA of ₹1,191 crores (29% growth, 15.6% margin) and PAT up 32% YoY to ₹630 crores. Healthcare Services revenue grew 23% to ₹3,900 crores (established hospitals 19% growth, 25.8% EBITDA margin, +61 bps), while Apollo HealthCo EBITDA grew 75% to ₹193 crores with 24/7 turning cash positive at ₹1 crore (vs ₹39 crores loss last year). H1 consolidated revenue grew 22% to ₹14,547 crores with PAT up 33% to ₹1,211 crores.

Earnings Call Summary
PREMIUM
PREMIUM
Unlock Comprehensive Analysis
Get deeper insights with detailed financials, forecasts, ratios & valuation
Revenue & Gross Margin
EBITDA & Dividend
Balance Sheet
DuPont & Ratio Analysis
Key Insights
Charts
Premium insights for smarter investing

Upgrade to access institutional-quality research & analysis.

Upgrade to Access
30-Day Free Trial
Disclaimer

The research report presented here is for informational and research purposes only. It reflects our own views, assumptions, and analysis and is not intended as a recommendation, offer, or solicitation to buy, sell, or hold any security or asset. Please conduct your own due diligence and consult a qualified financial advisor before making any investment decision. Please check our Terms & Conditions page before investing.

Scroll to Top